Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP189658.RA2hMz9WWq_tRGWNm2JuRnx4zlOZ0YOYyiX8HGgBw9iP0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP189658.RA2hMz9WWq_tRGWNm2JuRnx4zlOZ0YOYyiX8HGgBw9iP0130_assertion type Assertion NP189658.RA2hMz9WWq_tRGWNm2JuRnx4zlOZ0YOYyiX8HGgBw9iP0130_head.
- NP189658.RA2hMz9WWq_tRGWNm2JuRnx4zlOZ0YOYyiX8HGgBw9iP0130_assertion description "[The MEF2A mutations may account for up to 1.93% of the disease population; thus, genetic testing based on mutational analysis of MEF2A may soon be available for many coronary artery disease/myocardial infarction patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP189658.RA2hMz9WWq_tRGWNm2JuRnx4zlOZ0YOYyiX8HGgBw9iP0130_provenance.
- NP189658.RA2hMz9WWq_tRGWNm2JuRnx4zlOZ0YOYyiX8HGgBw9iP0130_assertion evidence source_evidence_literature NP189658.RA2hMz9WWq_tRGWNm2JuRnx4zlOZ0YOYyiX8HGgBw9iP0130_provenance.
- NP189658.RA2hMz9WWq_tRGWNm2JuRnx4zlOZ0YOYyiX8HGgBw9iP0130_assertion SIO_000772 15861005 NP189658.RA2hMz9WWq_tRGWNm2JuRnx4zlOZ0YOYyiX8HGgBw9iP0130_provenance.
- NP189658.RA2hMz9WWq_tRGWNm2JuRnx4zlOZ0YOYyiX8HGgBw9iP0130_assertion wasDerivedFrom lhgdn-20090331 NP189658.RA2hMz9WWq_tRGWNm2JuRnx4zlOZ0YOYyiX8HGgBw9iP0130_provenance.
- NP189658.RA2hMz9WWq_tRGWNm2JuRnx4zlOZ0YOYyiX8HGgBw9iP0130_assertion wasGeneratedBy ECO_0000203 NP189658.RA2hMz9WWq_tRGWNm2JuRnx4zlOZ0YOYyiX8HGgBw9iP0130_provenance.